Milne Jill C.
Insider CIK 1644246 · CATB President and CEO, Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,288 | $9.70 | $12.5K | 33,226 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,288 | $9.70 | $12.5K | 33,226 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 31,938 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-05-29 | 2026-06-02 | 1,262 | $8.91 | $11.2K | 16,644 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-02-27 | 2026-03-03 | 528 | $8.75 | $4.6K | 15,382 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 195,000 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 761,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-01-23 | 2026-01-27 | 26,684 | — | $0 | 26,684 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer | 2026-01-23 | 2026-01-23 | 4,377 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-01-23 | 2026-01-27 | 12,272 | — | $0 | 14,854 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-01-23 | 2026-01-27 | 2,582 | — | $0 | 2,582 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-03-21 | 2025-03-25 | 761,000 | — | $0 | 761,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-02-08 | 2024-02-12 | 534,600 | — | $0 | 534,600 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 195,000 | — | $0 | 195,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 1,400,000 | — | $0 | 1,400,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-02-12 | 2020-02-14 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-02-13 | 2019-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-09-07 | 2018-09-11 | 230,000 | — | $0 | 230,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-02-08 | 2018-02-09 | 230,000 | — | $0 | 230,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-02-09 | 2017-02-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-09-08 | 2016-09-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-09-08 | 2016-09-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-02-11 | 2016-02-16 | 103,000 | — | $0 | 103,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2015-07-17 | 2015-07-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 856,548 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 105,229 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 8,189 | — | $0 | 253,872 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 66,657 | — | $0 | 245,683 | SEC↗ |